⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 26, 2021Blood AdvancesOpen Access

BiTEs better than CAR T cells

Marion Subklewe

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

This article has a companion Point by Molina and Shah.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marion Subklewe (2021) studied this question.

synapsesocial.com/papers/6a11ffdfae8fb4569ad208d2 https://doi.org/10.1182/bloodadvances.2020001792

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Glofitamab with polatuzumab vedotin in relapsed/refractory central nervous system lymphomasBlood Advances · Wed,
2Prospective phase 2 trial of high- and intermediate-intensity myeloablative conditioning for cord blood transplantationBlood Advances · Wed,
3High Initial Dose and Accelerated vs. Slow Titration Ropeginterferon Alfa-2b for Polycythemia Vera: A Meta-AnalysisBlood Advances · Wed,
4Hematopoietic Cell Transplantation Outcomes in the Era of Post-Transplant Cyclophosphamide: Comprehensive Donor AnalysisBlood Advances · Wed,
5Advancing Sickle Cell Disease Care Through Collaboration: the HHS and ASH Registry Leaders' Roundtable InitiativeBlood Advances · Mon,

More from Blood Advances

National Alliance of Sickle Cell Disease Consensus Recommendations for Gene Therapy ImplementationMon,
Clinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutationFri,
Loncastuximab and Rituximab in Elderly Unfit/Frail Patients With Previously Untreated Diffuse Large B-Cell LymphomaThu,
Prognosis and treatment-related toxicities in Down syndrome acute lymphoblastic leukemia in JCCG ALL-B12Thu,
Persistent Thromboxane Biosynthesis Despite Aspirin Therapy Predicts PreeclampsiaThu,